TrueBlue, Inc. (TBI) Stock Forecast
TBI analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 2 analysts
- Price target
- $9.75 average of analyst targets
- Upside to target
- +17.8% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.21
- 52-week range
- $3.31 – $10.85
TBI analyst ratings
2 analystsNumber of analysts at each rating.
TBI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TBI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.19 | $0.16 | $0.21 | $0.03 | +522.2% | 3 |
| Current fiscal year (2026) | −$0.02 | −$0.10 | $0.06 | −$0.68 | +97.5% | 3 |
| Next fiscal year (2027) | $0.82 | $0.78 | $0.88 | −$0.02 | +4,999.0% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TBI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $468.1M | $464.8M | $471.3M | +8.5% | 2 |
| Current fiscal year (2026) | $1.75B | $1.73B | $1.76B | +8.1% | 2 |
| Next fiscal year (2027) | $1.81B | $1.73B | $1.88B | +3.3% | 2 |
TBI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TBI revenue: reported and forecast
TBI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.17 | $0.19 | $0.19 | $0.19 | $0.19 | +7.7% | 2 up · 0 down |
| Current fiscal year (2026) | −$0.24 | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −93.1% | 0 up · 0 down |
| Next fiscal year (2027) | $0.62 | $0.82 | $0.82 | $0.82 | $0.82 | +31.0% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TBI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TBI beat in 8 of 12.
What analysts expect from TBI
2 analysts cover TrueBlue; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $9.75, 17.8% above the latest close of $8.28. Analysts expect earnings of −$0.02 per share for 2026, +97.5% from a year earlier. For 2027 the average estimate is $0.82 per share on revenue of $1.8 billion. TrueBlue beat the EPS estimate in 8 of the last 12 quarters.
Related: TBI income statement, TBI key metrics, TBI chart. See the TBI stock overview for the latest quote and news.
TBI forecast FAQ
What is TrueBlue's price target?
The average analyst price target for TrueBlue is $9.75, 17.8% above the latest close of $8.28.
Is TrueBlue a buy, hold or sell?
Of 2 analysts covering TrueBlue, 1 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is TrueBlue's EPS forecast?
Analysts forecast −$0.02 per share for 2026 (range −$0.10 to $0.06); for 2027 the estimate is $0.82.
What is TrueBlue's revenue forecast?
The average revenue estimate for 2026 is $1.7 billion, growth of 8.1%; for 2027 it is $1.8 billion.
When does TrueBlue report earnings?
TrueBlue is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.21.
Does TrueBlue usually beat earnings estimates?
TrueBlue reported EPS at or above the analyst estimate in 8 of the last 12 quarters.